[go: up one dir, main page]

AU1085183A - Treating multiple sclerosis with dihydro-cyclosporin d - Google Patents

Treating multiple sclerosis with dihydro-cyclosporin d

Info

Publication number
AU1085183A
AU1085183A AU10851/83A AU1085183A AU1085183A AU 1085183 A AU1085183 A AU 1085183A AU 10851/83 A AU10851/83 A AU 10851/83A AU 1085183 A AU1085183 A AU 1085183A AU 1085183 A AU1085183 A AU 1085183A
Authority
AU
Australia
Prior art keywords
cyclosporin
dihydro
multiple sclerosis
treating multiple
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU10851/83A
Other versions
AU558155B2 (en
Inventor
Salvatore Cammisuli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU1085183A publication Critical patent/AU1085183A/en
Application granted granted Critical
Publication of AU558155B2 publication Critical patent/AU558155B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10851/83A 1982-02-01 1983-01-28 Treating multiple sclerosis with dihydro-cyclosporin d Ceased AU558155B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202776 1982-02-01
GB8202776 1982-02-01

Publications (2)

Publication Number Publication Date
AU1085183A true AU1085183A (en) 1983-08-11
AU558155B2 AU558155B2 (en) 1987-01-22

Family

ID=10528015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10851/83A Ceased AU558155B2 (en) 1982-02-01 1983-01-28 Treating multiple sclerosis with dihydro-cyclosporin d

Country Status (5)

Country Link
JP (1) JPS58134031A (en)
AU (1) AU558155B2 (en)
BE (1) BE895724A (en)
IT (1) IT1197556B (en)
PH (1) PH19156A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US6420355B2 (en) 1992-09-25 2002-07-16 Novartis Ag Pharmaceutical compositions containing cyclosporins

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
EP0170623B1 (en) * 1984-08-02 1990-11-28 Sandoz Ag Novel pharmaceutical use of (nva)2-cyclosporine
JP2577049B2 (en) * 1987-06-04 1997-01-29 三共株式会社 Cyclosporine preparation
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ES2098739T3 (en) 1992-05-13 1997-05-01 Sandoz Ltd OPHTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN.
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
DE4329503A1 (en) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmaceutical preparations for the targeted treatment of Crohn's disease and ulcerative colitis
ES2177652T3 (en) 1994-11-03 2002-12-16 Novartis Ag NEW FORMS OF PREPARATION OF CYCLOSPORINE FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY, AND PROCEDURE FOR OBTAINING IT.
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
EP1331002A3 (en) 1997-01-30 2004-01-14 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin A
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (en) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
WO2009042892A1 (en) * 2007-09-26 2009-04-02 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420355B2 (en) 1992-09-25 2002-07-16 Novartis Ag Pharmaceutical compositions containing cyclosporins
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US6503883B1 (en) 1993-09-01 2003-01-07 Novartis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis

Also Published As

Publication number Publication date
IT1197556B (en) 1988-12-06
PH19156A (en) 1986-01-15
IT8347644A0 (en) 1983-02-01
JPS58134031A (en) 1983-08-10
BE895724A (en) 1983-07-28
AU558155B2 (en) 1987-01-22

Similar Documents

Publication Publication Date Title
AU1146383A (en) Amidoximeguinolines
AU1383083A (en) Ligator-clip
AU1115783A (en) Quadricycle
AU1491183A (en) Curler-styler
AU1659483A (en) 14-fluoromorphinans
AU1112583A (en) Pyrazolo-quinolines, -thiazines and -oxazines
AU558155B2 (en) Treating multiple sclerosis with dihydro-cyclosporin d
AU1649683A (en) 1-dethia-1-oxa-3-cephem-derivatives
AU1315083A (en) Massage-douche
AU1557383A (en) Hestesko
AU1602483A (en) Sectionaliser
AU1475883A (en) Dosierpumpe
AU1395383A (en) Benzoazacycloalkyl-spiro-imidazolidines
AU1227483A (en) Klaranlage
AU1636583A (en) 19-thio-androstanes
AU1476983A (en) Bomanordning
AU1471483A (en) Tallerkenknuser
AU1553583A (en) Arbeitsmaschine
AU1674883A (en) Interferon-epsilon
AU1089783A (en) N-benzothienylalkyl-n-alkyl-allylamines
AU1222883A (en) Transmissionsmekanisme
AU1087683A (en) Oxazolidin-2-ones
AU1277283A (en) N-substituted-tetrahydrothiazines
AU563551B2 (en) Injector
AU1583483A (en) N-dichlorofluoromethanesulphenylhydantoins